Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$45.29 USD
-2.17 (-4.57%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $45.30 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
QTTB 45.29 -2.17(-4.57%)
Will QTTB be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for QTTB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for QTTB
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 91.69%: Read This Before Placing a Bet
QTTB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for QTTB
Q32 Bio Inc Reports Q3 2024 Net Loss of $1.46 Per Share with Revenue Focus on Clinical Progress
Q32 Bio Advances Clinical Trials Amidst Financial Challenges
Q32 Bio Inc Grapples with Internal Control Challenges Amid Compliance Costs
Q32 Bio reports Q3 EPS ($1.46), consensus ($1.40)
Q32 Bio GAAP EPS of -$1.46